Related references
Note: Only part of the references are listed.An expanded universe of cancer targets
William C. Hahn et al.
CELL (2021)
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti-Proliferative Activity in Lung Cancer Cells
Zhangping Xiao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
D-dopachrome tautomerase contributes to lung epithelial repair via atypical chemokine receptor 3-dependent Akt signaling
Shanshan Song et al.
EBIOMEDICINE (2021)
Structure-activity relationships for binding of 4-substituted triazole-phenols to macrophage migration inhibitory factor (MIF)
Zhangping Xiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
Eugenio Cavalli et al.
MOLECULES (2020)
CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer
Benedikt Jaeger et al.
CELLULAR SIGNALLING (2020)
Immune modulation by the macrophage migration inhibitory factor (MIF) family: D-dopachrome tautomerase (DDT) is not (always) a backup system
Oscar Illescas et al.
CYTOKINE (2020)
7-Hydroxycoumarins Are Affinity-Based Fluorescent Probes for Competitive Binding Studies of Macrophage Migration Inhibitory Factor
Zhangping Xiao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
Manish Charan et al.
CELL DEATH & DISEASE (2020)
Regulation of MIF Enzymatic Activity by an Allosteric Site at the Central Solvent Channel
Georgios Pantouris et al.
CELL CHEMICAL BIOLOGY (2020)
A Thieno[2,3-d]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D2 Receptor
Tim J. Fyfe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
Justin C. Penticuff et al.
NATURE REVIEWS UROLOGY (2019)
Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
Laura Soumoy et al.
CANCERS (2019)
A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity
Pathricia Veronica Tilstam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Structural Plasticity in the C-Terminal Region of Macrophage Migration Inhibitory Factor-2 Is Associated with an Induced Fit Mechanism for a Selective Inhibitor
Georgios Pantouris et al.
BIOCHEMISTRY (2018)
Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor
Vinay Trivedi-Parmar et al.
CHEMMEDCHEM (2018)
Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor
Vinay Trivedi-Parmar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Bio-inspired enantioselective full transamination using readily available cyclodextrin
Shiqi Zhang et al.
RSC ADVANCES (2017)
PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer (mCRC)
D. Mahalingam et al.
ANNALS OF ONCOLOGY (2016)
Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties
Nikolaos Eleftheriadis et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development
Joshua Bloom et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth
Dawei Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment
M. Zhang et al.
CANCER GENE THERAPY (2015)
An Analysis of MIF Structural Features that Control Functional Activation of CD74
Georgios Pantouris et al.
CHEMISTRY & BIOLOGY (2015)
Discovery of New H2S Releasing Phosphordithioates and 2,3-Dihydro-2-phenyl-2-sulfanylenebenzo[d][1,3,2]oxazaphospholes with Improved Antiproliferative Activity
Wei Feng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design, Synthesis, and Protein Crystallography of Biaryltriazoles as Potent Tautomerase Inhibitors of Macrophage Migration Inhibitory Factor
Pawel Dziedzic et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma
Camila S. Oliveira et al.
BMC CANCER (2014)
Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment
Deepa Rajasekaran et al.
FASEB JOURNAL (2014)
Dysregulated D-dopachrome Tautomerase, a Hypoxia-inducible Factor-dependent Gene, Cooperates with Macrophage Migration Inhibitory Factor in Renal Tumorigenesis
Vinay Pasupuleti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model
Sebastian Kobold et al.
ONCOTARGET (2014)
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
Maria Vinci et al.
BMC BIOLOGY (2012)
MIF as a disease target: ISO-I as a proof-of-concept therapeutic
Yousef Al-Abed et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry
Minoru Ishikawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)
Melanie Merk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
Yoonsang Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Kinetic-Based High-Throughput Screening Assay to Discover Novel Classes of Macrophage Migration Inhibitory Factor Inhibitors
Hajer Ouertatani-Sakouhi et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase
Arlixer M. Coleman et al.
JOURNAL OF IMMUNOLOGY (2008)
Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment
Christian Weber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
Juergen Bernhagen et al.
NATURE MEDICINE (2007)
Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells
Katherine L. Meyer-Siegler et al.
JOURNAL OF IMMUNOLOGY (2006)
CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex
Xuerong Shi et al.
IMMUNITY (2006)
MIF signal transduction initiated by binding to CD74
L Leng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position:: A highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor
S Sasaki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Share Paper
